x

Posted 20 July, 2023

Item 9 Labs Corp. appointed new CEO

CEO Change detected for ticker OTC:INLB in a 8-K filed on 20 July, 2023.


  As such, Douglas Bowden has resigned his positions as Chairman of the Board of Directors and Interim CEO of Item 9 Labs Corp, effective July 18, 2023.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Item 9 Labs Corp.
Consumer Goods • Personal Care Products/Appliances
Item 9 Labs Corp. is a vertically integrated cannabis operator and dispensary franchisor. It operates through the Cultivation and Franchising segments. The Cultivation segment produces cannabis and cannabis-derived products and technologies through its Item 9 Labs brand. The Franchising segment sells medical and adult-use cannabis dispensary franchises under its franchise brand, Unity Rd. Its products include Orion, cartridges, flowers, pre-rolls, live resin sugar, live resin badder, and crumble. The company was founded on June 15, 2010 and is headquartered in Phoenix, AZ.
Market Cap
$40.9K
View Company Details
Item 9 Labs Corp. by TradingView
Relevant filing section
Item 5.02 Departure of Directions or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officer 


Douglas Bowden - Resignation


As described above in Item 1.03, two entities in which Douglas Bowden has controlling interest in requested the Court to appoint a receiver of Item 9 Labs Corp. As such, Douglas Bowden has resigned his positions as Chairman of the Board of Directors and Interim CEO of Item 9 Labs Corp, effective July 18, 2023. The positions will be left vacant until further notice due to the receivership appointment.